Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
4.18
0.00 (0.00%)
At close: Sep 04, 2025, 3:59 PM
4.18
0.00%
After-hours: Sep 04, 2025, 04:10 PM EDT
0.00% (1D)
| Bid | 4.09 |
| Market Cap | 284.47M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -122.47M |
| EPS (ttm) | -2.36 |
| PE Ratio (ttm) | -1.77 |
| Forward PE | -59.71 |
| Analyst | Buy |
| Ask | 4.27 |
| Volume | 641,934 |
| Avg. Volume (20D) | 1,138,261 |
| Open | 4.16 |
| Previous Close | 4.18 |
| Day's Range | 4.07 - 4.25 |
| 52-Week Range | 2.95 - 13.60 |
| Beta | 2.37 |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Omeros Corporation is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
8 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
2 months ago · businesswire.com
Omeros Announces Webcast Details for Annual Meeting of ShareholdersSEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Friday, Jun...
